Incannex Healthcare (IXHL) Assets (2020 - 2026)
Incannex Healthcare (IXHL) posted quarterly Assets of $80.3 million for Q1 2026, up 395.67% year-on-year from $16.2 million in Q1 2025, and up 7.04% on a QoQ basis from $75.0 million in Q4 2025.
Incannex Healthcare (IXHL) Assets (2020 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Assets for 7 consecutive years, with $80.3 million the latest figure, recorded in Q1 2026.
- Quarterly Assets rose 395.67% year-over-year to $80.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $80.3 million (up 395.67% YoY) and the FY2025 annual result came in at $20.4 million, up 19.94% from the prior year.
- Assets rose to $80.3 million in Q1 2026 per IXHL's latest filing, from $75.0 million in the prior quarter.
- Over the last five years, Assets for IXHL reached as high as $95.2 million in Q4 2022 and fell as low as $11.1 million in Q4 2024.
- A 5-year average of $39.3 million and a median of $22.4 million in 2023 frame the typical range for Assets.
- Annual changes were most pronounced in 2023 — Assets sank 76.52% — and 2025, when it surged 575.36%.
- Year by year, Assets stood at $95.2 million in 2022, then plunged by 76.52% to $22.4 million in 2023, then sank by 50.33% to $11.1 million in 2024, then jumped by 575.36% to $75.0 million in 2025, then climbed by 7.04% to $80.3 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $80.3 million, $75.0 million, and $78.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.40 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.04 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.15 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 98.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.71 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 69.30 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 36.83 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.91 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.22 Bn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | 80.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.28 Mn |
| Dec 31, 2025 | 75.01 Mn |
| Sep 30, 2025 | 78.72 Mn |
| Jun 30, 2025 | 20.45 Mn |
| Mar 31, 2025 | 16.20 Mn |
| Dec 31, 2024 | 11.11 Mn |
| Sep 30, 2024 | 16.05 Mn |
| Jun 30, 2024 | 17.05 Mn |
| Mar 31, 2024 | 17.25 Mn |
| Dec 31, 2023 | 22.36 Mn |
| Jun 30, 2023 | 23.78 Mn |
| Dec 31, 2022 | 95.22 Mn |
| Jun 30, 2022 | 37.88 Mn |
| Jun 30, 2021 | 9.33 Mn |
| Jun 30, 2020 | 4.24 Mn |